0

511509

VIVOBIOT

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VIVO BIO TECH LTD. Share Price Today

Investment Returns

Over 1 Month -10.56% Over 3 Months -2.63% Over 6 Months -15.86% Over 1 Year -34.86%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VIVO BIO TECH LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 53.30
  • P/E Ratio (TTM) -27.62
  • Beta 1.05
  • Book Value / share 41.27
  • Return on equity 6.05%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -5.44
info icon alternate text

VIVO BIO TECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 13.77
Operating Expense 13.22
Net Profit -5.44
Net Profit Margin (%) -39.50
Earnings Per Share (EPS) -2.65
EBITDA 4.21
Effective Tax Rate (%) -27050.00
Particulars DEC 2025 (Values in Cr)
Revenue 13.37
Operating Expense 11.92
Net Profit 1.26
Net Profit Margin (%) 9.42
Earnings Per Share (EPS) 0.57
EBITDA 5.64
Effective Tax Rate (%) 20.25
Particulars SEP 2025 (Values in Cr)
Revenue 13.02
Operating Expense 11.64
Net Profit 0.87
Net Profit Margin (%) 6.68
Earnings Per Share (EPS) 0.45
EBITDA 5.55
Effective Tax Rate (%) 42.38
Particulars JUN 2025 (Values in Cr)
Revenue 12.42
Operating Expense 11.04
Net Profit 1.37
Net Profit Margin (%) 11.03
Earnings Per Share (EPS) 0.76
EBITDA 5.66
Effective Tax Rate (%) 9.21
Particulars MAR 2025 (Values in Cr)
Revenue 12.29
Operating Expense 11.08
Net Profit 1.19
Net Profit Margin (%) 9.68
Earnings Per Share (EPS) 0.78
EBITDA 5.29
Effective Tax Rate (%) 13.23
Particulars MAR 2026 (Values in Cr)
Revenue 52.57
Operating Expense 47.82
Net Profit -1.94
Net Profit Margin (%) -3.69
Earnings Per Share (EPS) -0.93
EBITDA 21.06
Effective Tax Rate (%) 142.35
Particulars MAR 2025 (Values in Cr)
Revenue 46.67
Operating Expense 42.39
Net Profit 7.57
Net Profit Margin (%) 16.22
Earnings Per Share (EPS) 4.95
EBITDA 25.59
Effective Tax Rate (%) 16.62
Particulars MAR 2024 (Values in Cr)
Revenue 44.88
Operating Expense 40.87
Net Profit 2.52
Net Profit Margin (%) 5.61
Earnings Per Share (EPS) 1.69
EBITDA 21.11
Effective Tax Rate (%) 37.77
Particulars MAR 2023 (Values in Cr)
Revenue 51.62
Operating Expense 47.05
Net Profit 2.63
Net Profit Margin (%) 5.09
Earnings Per Share (EPS) 1.77
EBITDA 21.53
Effective Tax Rate (%) 42.73
Particulars MAR 2022 (Values in Cr)
Revenue 51.39
Operating Expense 47.01
Net Profit 2.20
Net Profit Margin (%) 4.28
Earnings Per Share (EPS) 1.56
EBITDA 15.90
Effective Tax Rate (%) 50.78
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.15
ROE % 5.68
ROCE % 8.99
Total Debt to Total Equity 0.96
EBITDA Margin 44.45
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.50
ROE % 4.76
ROCE % 9.88
Total Debt to Total Equity 1.27
EBITDA Margin 46.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.81
ROE % 5.35
ROCE % 10.97
Total Debt to Total Equity 1.31
EBITDA Margin 41.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 32.56
ROE % 4.91
ROCE % 9.25
Total Debt to Total Equity 1.10
EBITDA Margin 31.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.63
ROE % 15.03
ROCE % 18.65
Total Debt to Total Equity 0.73
EBITDA Margin 34.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.32
ROE % 6.05
ROCE % 9.37
Total Debt to Total Equity 0.93
EBITDA Margin 45.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.50
ROE % 4.74
ROCE % 10.06
Total Debt to Total Equity 1.23
EBITDA Margin 47.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.81
ROE % 5.31
ROCE % 11.16
Total Debt to Total Equity 1.27
EBITDA Margin 42.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 32.57
ROE % 4.91
ROCE % 9.47
Total Debt to Total Equity 1.05
EBITDA Margin 31.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.64
ROE % 15.03
ROCE % 19.31
Total Debt to Total Equity 0.67
EBITDA Margin 34.53
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 143.23
Total Liabilities 143.23
Total Equity 77.90
Share Outstanding 1
Price to Book Ratio 0.82
Return on Assets (%) 5.08
Return on Capital (%) 5.52
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.38
Total Assets 137.13
Total Liabilities 137.13
Total Equity 54.39
Share Outstanding 1
Price to Book Ratio 1.17
Return on Assets (%) 1.84
Return on Capital (%) 1.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.37
Total Assets 123.03
Total Liabilities 123.03
Total Equity 51.87
Share Outstanding 1
Price to Book Ratio 0.55
Return on Assets (%) 2.15
Return on Capital (%) 2.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.71
Total Assets 122.48
Total Liabilities 122.48
Total Equity 47.12
Share Outstanding 1
Price to Book Ratio 1.22
Return on Assets (%) 1.79
Return on Capital (%) 1.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.16
Total Assets 79.52
Total Liabilities 79.52
Total Equity 42.52
Share Outstanding 1
Price to Book Ratio 1.56
Return on Assets (%) 7.14
Return on Capital (%) 7.73
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.20
Total Assets 141.28
Total Liabilities 141.28
Total Equity 78.19
Share Outstanding 1
Price to Book Ratio 0.82
Return on Assets (%) 5.35
Return on Capital (%) 5.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.31
Total Assets 134.80
Total Liabilities 134.80
Total Equity 54.39
Share Outstanding 1
Price to Book Ratio 1.17
Return on Assets (%) 1.87
Return on Capital (%) 2.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.99
Total Assets 120.80
Total Liabilities 120.80
Total Equity 51.87
Share Outstanding 1
Price to Book Ratio 0.55
Return on Assets (%) 2.18
Return on Capital (%) 2.35
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.46
Total Assets 120.29
Total Liabilities 120.29
Total Equity 47.14
Share Outstanding 1
Price to Book Ratio 1.22
Return on Assets (%) 1.83
Return on Capital (%) 1.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 77.30
Total Liabilities 77.30
Total Equity 42.54
Share Outstanding 1
Price to Book Ratio 1.56
Return on Assets (%) 7.35
Return on Capital (%) 7.98
Particulars MAR 2025 (Values in Cr)
Net Income 8.79
Cash from Operations 15.37
Cash from Investing -15.84
Cash from Financing 3.90
Net change in Cash -0.10
Free Cash Flow 37.64
Particulars MAR 2024 (Values in Cr)
Net Income 4.06
Cash from Operations 18.58
Cash from Investing -7.95
Cash from Financing -7.55
Net change in Cash 0.01
Free Cash Flow 26.53
Particulars MAR 2023 (Values in Cr)
Net Income 4.62
Cash from Operations 18.17
Cash from Investing -3.99
Cash from Financing -11.17
Net change in Cash -0.33
Free Cash Flow 22.17
Particulars MAR 2022 (Values in Cr)
Net Income 4.47
Cash from Operations 20.09
Cash from Investing -51.11
Cash from Financing 35.01
Net change in Cash 0.54
Free Cash Flow 71.20
Particulars MAR 2021 (Values in Cr)
Net Income 8.61
Cash from Operations 20.64
Cash from Investing -22.82
Cash from Financing 8.78
Net change in Cash 0.13
Free Cash Flow 43.46
Particulars MAR 2025 (Values in Cr)
Net Income 9.08
Cash from Operations 15.94
Cash from Investing -15.84
Cash from Financing 3.90
Net change in Cash -0.10
Free Cash Flow 38.21
Particulars MAR 2024 (Values in Cr)
Net Income 4.05
Cash from Operations 18.88
Cash from Investing -7.95
Cash from Financing -7.55
Net change in Cash 0.32
Free Cash Flow 26.83
Particulars MAR 2023 (Values in Cr)
Net Income 4.60
Cash from Operations 18.06
Cash from Investing -3.99
Cash from Financing -11.20
Net change in Cash -0.47
Free Cash Flow 22.06
Particulars MAR 2022 (Values in Cr)
Net Income 4.47
Cash from Operations 19.88
Cash from Investing -51.10
Cash from Financing 35.04
Net change in Cash 0.36
Free Cash Flow 70.99
Particulars MAR 2021 (Values in Cr)
Net Income 8.62
Cash from Operations 20.56
Cash from Investing -22.82
Cash from Financing 8.83
Net change in Cash 0.10
Free Cash Flow 43.38
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

VIVO BIO TECH LTD. shareholding pattern

Holding
64.57%
35.42%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VIVO BIO TECH LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
24.03 0.00 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 24.00
  • 26 Days 25.00
  • 10 Days 24.10
  • 50 Days 25.70
  • 12 Days 24.20
  • 100 Days 27.00
  • 20 Days 24.70
  • 200 Days 29.40
24.11 PIVOT
First Support 23.72 First Resistance 24.43 Second Support 23.40 Second Resistance 24.82 Third Support 23.01 Third Resistance 25.14
RSI 41.64 ADX 6.40 MACD -0.76 Williams % R -43.07 Commodity Channel Index (CCI) -31.36
Date 2026-06-19 Week 7469.00 Same Day 10142.00 Month 57049.00
1 Year 1.05 3 Year 0.67
Over 1 Month
-10.56% down
Over 1 Year
-34.86% down
Over 3 Months
-2.63% down
Over 3 Years
-6.80% down
Over 6 Months
-15.86% down
Over 5 Years
-23.21% down

VIVO BIO TECH LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vivo Bio Tech Ltd?

Answer Field

Vivo Bio Tech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 24.03 as on Jun 19 2026 03:30 PM.

What is the Market Cap of Vivo Bio Tech Ltd Share?

Answer Field

The market cap of Vivo Bio Tech Ltd for NSE ₹ 0.00 & for BSE ₹ 53.30 as on Jun 19 2026 03:30 PM.

What is the 52 Week High and Low of Vivo Bio Tech Ltd?

Answer Field

The 52 Week High and Low of Vivo Bio Tech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 43.35 and ₹ 20.35.

What is 1 year return for Vivo Bio Tech Ltd?

Answer Field

The 1 year returns on the stock has been -34.86%.

What is the P/E Ratio of Vivo Bio Tech Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM the price-to-earnings (PE) ratio for Vivo Bio Tech Ltd share is -27.62.

What is the PB ratio of Vivo Bio Tech Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM, the price-to-book (PB) ratio for Vivo Bio Tech Ltd share is 41.27.

How to Buy Vivo Bio Tech Ltd Share?

Answer Field

You can trade in Vivo Bio Tech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vivo Bio Tech Ltd Share on Bajaj Broking App?

Answer Field

To buy Vivo Bio Tech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vivo Bio Tech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|